BACH1 and esophageal cancer: An increased expression of BACH1 was shown to be correlated with a poorer prognosis of patients with breast, pancreatic, colorectal, ovarian, and esophageal cancers as well as glioblastoma (79, 80, 81, 84, 85, 86).